Institut de recherches cliniques de Montréal, Canada.
Blood. 2010 Dec 9;116(24):5149-61. doi: 10.1182/blood-2010-04-280305. Epub 2010 Sep 8.
Donor-matched transplantation of hematopoietic stem cells (HSCs) is widely used to treat hematologic malignancies but is associated with high mortality. The expansion of HSC numbers and their mobilization into the bloodstream could significantly improve therapy. We report here that adult mice conditionally deficient for the transcription Growth factor independence 1b (Gfi1b) show a significant expansion of functional HSCs in the bone marrow and blood. Despite this expansion, Gfi1b(ko/ko) HSCs retain their ability to self-renew and to initiate multilineage differentiation but are no longer quiescent and contain elevated levels of reactive oxygen species. Treatment of Gfi1b(ko/ko) mice with N-acetyl-cystein significantly reduced HSC numbers indicating that increased reactive oxygen species levels are at least partially responsible for the expansion of Gfi1b-deficient HSCs. Moreover, Gfi1b(-/-) HSCs show decreased expression of CXCR4 and Vascular cell adhesion protein-1, which are required to retain dormant HSCs in the endosteal niche, suggesting that Gfi1b regulates HSC dormancy and pool size without affecting their function. Finally, the additional deletion of the related Gfi1 gene in Gfi1b(ko/ko) HSCs is incompatible with the maintenance of HSCs, suggesting that Gfi1b and Gfi1 have partially overlapping functions but that at least one Gfi gene is essential for the generation of HSCs.
造血干细胞(HSCs)供体匹配移植被广泛用于治疗血液系统恶性肿瘤,但与高死亡率相关。HSC 数量的扩增及其向血液中的动员可能会显著改善治疗效果。我们在此报告,条件性缺乏转录因子生长因子独立性 1b(Gfi1b)的成年小鼠在骨髓和血液中显示出功能性 HSCs 的显著扩增。尽管存在这种扩增,但 Gfi1b(ko/ko)HSCs 仍然保留其自我更新和启动多谱系分化的能力,但不再静止,并且含有高水平的活性氧。用 N-乙酰半胱氨酸治疗 Gfi1b(ko/ko)小鼠可显著减少 HSC 数量,表明活性氧水平的升高至少部分导致了 Gfi1b 缺陷 HSC 的扩增。此外,Gfi1b(-/-)HSCs 显示出 CXCR4 和血管细胞黏附蛋白-1 的表达降低,这些蛋白是将休眠 HSC 保留在内骨皮质龛中的必需条件,表明 Gfi1b 调节 HSC 休眠和池大小,而不影响其功能。最后,在 Gfi1b(ko/ko)HSCs 中进一步缺失相关的 Gfi1 基因与 HSC 的维持不兼容,表明 Gfi1b 和 Gfi1 具有部分重叠的功能,但至少有一个 Gfi 基因是生成 HSC 的必要条件。